Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Filing Details

Accession Number:
0001140361-19-021634
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-11-27 16:17:50
Reporting Period:
2019-11-26
Accepted Time:
2019-11-27 16:17:50
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1661181 Organogenesis Holdings Inc. ORGO () DE
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1069096 Thompson Dean C/o Avista Capital Partners
65 East 55Th Street, 18Th Floor
New York NY 10022
No No No No
1374179 F David Burgstahler C/o Avista Capital Partners
65 East 55Th Street, 18Th Floor
New York NY 10022
No No No No
1661187 Avista Acquisition Corp. 65 East 55Th Street
18Th Floor
New York NY 10022
No No No No
1664173 Avista Capital Partners (Offshore) Iv, L.p. C/o Avista Capital Partners
65 East 55Th Street, 18Th Floor
New York NY 10022
No No No No
1664176 Avista Capital Partners Iv, L.p. C/o Avista Capital Partners
65 East 55Th Street, 18Th Floor
New York NY 10022
No No No No
1686388 Avista Acquisition, Llc 65 East 55Th Street
18Th Floor
New York NY 10022
No No No No
1761175 Avista Capital Managing Member Iv, Llc C/o Avista Capital Partners
65 East 55Th Street, 18Th Floor
New York NY 10022
No No No No
1761195 Avista Capital Partners Iv Gp, L.p. C/o Avista Capital Partners
65 East 55Th Street, 18Th Floor
New York NY 10022
No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Class A Common Stock Acquisiton 2019-11-26 6,000,000 $5.00 24,975,165 No 4 P Indirect See Notes
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect See Notes
Footnotes
  1. This statement is being filed by the following Reporting Persons: Avista Acquisition Corp. (the "Sponsor"); Avista Acquisition LLC, which is the sole shareholder of the Sponsor; Avista Capital Partners IV, L.P. ("ACP Onshore"); Avista Capital Partners (Offshore) IV, L.P. ("ACP Offshore" and together with ACP Onshore, the "Avista Funds"); Avista Capital Partners IV GP, L.P. ("Avista GP"), which is the general partner of ACP Onshore and ACP Offshore; Avista Capital Managing Member IV, LLC, which is the general partner of Avista GP; Thompson Dean; and David Burgstahler.
  2. Represents an aggregate of 3,008,064 shares of Common Stock purchased by ACP Onshore and 2,991,936 shares of Common Stock purchased by ACP Offshore in the Issuer's underwritten public offering (the "Offering") that was completed on November 26, 2019.
  3. Represents the public offering price of $5.00 per share of Common Stock, without giving effect to the fee paid by the Issuer to Avista Capital Holdings, L.P., an affiliate of the Avista Funds ("Avista Management"), pursuant to the Fee Letter Agreement, dated November 19, 2019, among the Issuer, Avista Management and the Avista Funds, made in connection with the Offering, as described in the Issuer's Current Report on Form 8-K filed on November 22, 2019 and filed as Exhibit 10.1 thereto.
  4. Because of the relationship among the Reporting Persons, the Reporting Persons may be deemed to beneficially own the securities reported herein to the extent of their respective pecuniary interests. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any. Joshua Tamaroff, an employee of an affiliate of the Reporting Persons, serves on the board of directors of the Issuer as a representative of the Reporting Persons.
  5. Pursuant to Rule 16a-1(a)(4) under the Exchange Act, this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests.